
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is a prominent player in the tissue and hygiene market, with over half of its sales derived from personal care products and an additional third from consumer tissue offerings. The company is poised for growth with an anticipated robust innovation pipeline in 2026, supported by advancements in technology that could enhance product offerings and market reach. Furthermore, the strategic addition of Kenvue's consumer health portfolio anticipated in the latter half of 2026 is likely to bolster Kimberly-Clark's overall revenue base and market presence, particularly in a competitive environment.
Bears say
Kimberly-Clark is experiencing a significant negative shift in its sales outlook, with a projected organic sales decline of -4.0% in North America for the third quarter of 2025, a stark contrast to the prior estimate of +4.5%. Additionally, the company reported a -2.7% decline in U.S. measured retail sales during the same timeframe, indicating persistent struggles in maintaining market performance. Earnings per share (EPS) estimates have been revised downward, with forecasts for fiscal year 2025 decreased from $7.60 to $7.41 and for 2026 from $8.00 to $7.85, which reflects ongoing challenges in profitability and revenue generation.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares